Ocean Biomedical Extends Patent Rights for Breakthrough Idiopathic Pulmonary Fibrosis Discovery To Europe

Ocean Biomedical (NASDAQ: OCEA) has been granted a European patent for its breakthrough Idiopathic Pulmonary Fibrosis discovery. The announcement comes after the European Patent Office granted Dr. Jack A. Elias, MD, Ocean Biomedical's Scientific Co-founder, a patent for Methods and Compositions relating to the treatment of fibrosis using Ocean’s anti-Chitinase 1 small molecule candidate (“Small ..